The National Institutes of Health (NIH) is gradually resuming important meetings and travel associated with the critical grant-review process following an agency-wide communications freeze at the Department of Health and Human Services (HHS).
While operations are on the path to normalization, they are not yet fully restored to pre-Trump administration levels. The advisory council and scientific review meetings linked to the NIH's grant-making process, where external scientists offer final grant reviews and strategic advice before new programs are finalized, have been ongoing but have not yet transitioned to open sessions.
